Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,635Revenue $M1,054Net Margin (%)16.6Z-Score2.2
Enterprise Value $M5,760EPS $-0.3Operating Margin %25.6F-Score3
P/E(ttm))0Cash Flow Per Share $2.2Pre-tax Margin (%)21.6Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %0Quick Ratio2.8Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %30.6Current Ratio3.0Lower Leverage y-yN
Price/Cash Flow18.6y-y EBITDA Growth Rate %-69.1ROA % (ttm)8.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M75.3ROI % (ttm)5.6Gross Margin Increase y-yN

Gurus Latest Trades with CBST

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CBSTLee Ainslie 2014-03-31 Buy 1.8%$67.2 - $81.23
($74.39)
$ 61.55-17%New holding, 1739818 sh.1,739,818
CBSTGeorge Soros 2014-03-31 Reduce-0.06%$67.2 - $81.23
($74.39)
$ 61.55-17%Reduce -65.4%50,000
CBSTJohn Burbank 2013-12-31 Sold Out -0.42%$61.59 - $70.76
($64.66)
$ 61.55-5%Sold Out0
CBSTJoel Greenblatt 2013-12-31 Sold Out -0.05%$61.59 - $70.76
($64.66)
$ 61.55-5%Sold Out0
CBSTJohn Burbank 2013-09-30 Buy 0.42%$51.58 - $66.54
($60.56)
$ 61.552%New holding, 202451 sh.202,451
CBSTMichael Price 2013-09-30 Sold Out -1.2%$51.58 - $66.54
($60.56)
$ 61.552%Sold Out0
CBSTGeorge Soros 2013-06-30 Buy 0.09%$44.66 - $56.11
($49.15)
$ 61.5525%New holding, 175000 sh.175,000
CBSTJohn Hussman 2013-03-31 Sold Out -0.75%$40.78 - $48.06
($44.18)
$ 61.5539%Sold Out0
CBSTJoel Greenblatt 2013-03-31 Reduce-0.18%$40.78 - $48.06
($44.18)
$ 61.5539%Reduce -72.24%28,134
CBSTJoel Greenblatt 2012-12-31 Buy 0.25%$39.17 - $48.63
($43.07)
$ 61.5543%New holding, 101334 sh.101,334
CBSTJoel Greenblatt 2012-09-30 Sold Out -0.12%$37.91 - $49.83
($43.89)
$ 61.5540%Sold Out0
CBSTJoel Greenblatt 2012-06-30 Add0.04%$38.38 - $44.07
($40.88)
$ 61.5551%Add 49.02%41,492
CBSTJohn Hussman 2012-03-31 Add0.18%$38.77 - $44.72
($38.64)
$ 61.5559%Add 47.16%674,000
CBSTJoel Greenblatt 2012-03-31 Reduce-0.17%$38.77 - $44.72
($38.64)
$ 61.5559%Reduce -55.29%27,844
CBSTGeorge Soros 2012-03-31 Sold Out -0.09%$38.77 - $44.72
($38.64)
$ 61.5559%Sold Out0
CBSTJohn Hussman 2011-12-31 Add0.26%$34.05 - $40.38
($37.51)
$ 61.5564%Add 798.04%458,000
CBSTJoel Greenblatt 2011-12-31 Reduce-0.42%$34.05 - $40.38
($37.51)
$ 61.5564%Reduce -53.85%62,273
CBSTGeorge Soros 2011-12-31 Reduce-0.03%$34.05 - $40.38
($37.51)
$ 61.5564%Reduce -50%50,000
CBSTMichael Price 2011-09-30 Add0.49%$29.59 - $36.93
($34.13)
$ 61.5580%Add 73.57%182,500
CBSTVanguard Health Care Fund 2011-09-30 Add0.08%$29.59 - $36.93
($34.13)
$ 61.5580%Add 49.25%1,323,142
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CBST is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CBST Lee Ainslie 2014-03-311,739,8182.311.8New Buy
CBST Vanguard Health Care Fund 2014-03-311,323,1421.760.27
CBST George Soros 2014-03-3150,0000.070.04-65.4%
Premium Most recent portfolio changes are included for Premium Members only!


CBST: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-07-28Sell40,625$61.57-0.03view
BONNEY MICHAEL WCEO 2014-05-15Sell3,036$67.5-8.81view
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-05-15Sell16,340$67.82-9.25view
PEREZ ROBERT JPresident & COO 2014-05-15Sell1,518$67.5-8.81view
STEA GREGORYSVP, Commercial Operations 2014-05-15Sell875$67.5-8.81view
TOMSICEK MICHAEL JOHNSVP & CFO 2014-05-14Sell499$69-10.8view
STEA GREGORYSVP, Commercial Operations 2014-05-14Sell865$69-10.8view
PEREZ ROBERT JPresident & COO 2014-05-14Sell2,400$69-10.8view
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-05-14Sell1,680$69-10.8view
BONNEY MICHAEL WCEO 2014-05-14Sell3,840$69-10.8view

Press Releases about CBST :

Quarterly/Annual Reports about CBST:

News about CBST:

Articles On GuruFocus.com
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
Michael Price’s Top Sells – 11 Gurus Exit SFD Nov 19 2013 
Magic Formula Formulator Joel Greenblatt’s Top 5 New Stock Picks Feb 14 2013 
5 Healthcare Stocks to Consider in 2012 Mar 21 2012 
Cubist Pharmaceutical - Acutely Aware May 09 2010 
Cubist Pharmaceutical - Acutely Aware May 09 2010 
Cubist Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Weekly CEO Sells Highlight: Saba Software Inc, Cubist Pharmaceuticals Inc, Polo Ralph Lauren Corp, P Apr 25 2010 
Cubist Pharmaceuticals Inc. (CBST) President and CEO Michael W Bonney sells 184,548 Shares Apr 23 2010 
Cubist Pharmaceuticals: A Drug Stock With Potential For Solid Gain Feb 15 2010 


More From Other Websites
Cubist to Present at August Investor Conference Jul 28 2014
Cubist to Present at August Investor Conference Jul 28 2014
Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales Jul 23 2014
Cubist Reports Second Quarter 2014 Financial Results Jul 22 2014
CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other... Jul 22 2014
Cubist Reports Second Quarter 2014 Financial Results Jul 22 2014
Q2 2014 Cubist Pharmaceuticals, Inc. Earnings Release - 4:00 pm ET Jul 22 2014
Top Biotech Earnings Previews for the Week Ahead Jul 20 2014
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 Jul 15 2014
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 Jul 15 2014
CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 14 2014
If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs? Jul 11 2014
[video] Cubist advances Sivextro Jun 23 2014
Cubist Pharmaceuticals (CBST) Is Water-Logged And Getting Wetter Today Jun 23 2014
Cubist Gains FDA Approval for Sivextro Jun 23 2014
Will This Price Target Increase Help Cubist Pharmaceuticals (CBST) Stock Today? Jun 23 2014
CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 23 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide